Coronavirus Update: US Adds To Antibody Push With $486m AstraZeneca Deal
Plus: Bharat To Start Phase III Vaccine Trials Shortly
After a week of monoclonal antibody therapies hitting the headlines - including a personal endorsement from President Trump - the US government bulks up its potential supplies. AZ's long-acting monoclonal antibody product enters large-scale trials for both a treatment and prophylaxis of COVID-19.
